Anish Suri

2.5k total citations
36 papers, 1.8k citations indexed

About

Anish Suri is a scholar working on Immunology, Genetics and Surgery. According to data from OpenAlex, Anish Suri has authored 36 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Immunology, 20 papers in Genetics and 7 papers in Surgery. Recurrent topics in Anish Suri's work include Immune Cell Function and Interaction (23 papers), T-cell and B-cell Immunology (19 papers) and Diabetes and associated disorders (18 papers). Anish Suri is often cited by papers focused on Immune Cell Function and Interaction (23 papers), T-cell and B-cell Immunology (19 papers) and Diabetes and associated disorders (18 papers). Anish Suri collaborates with scholars based in United States, United Kingdom and Australia. Anish Suri's co-authors include Emil R. Unanue, Boris Calderón, A Szállaśi, Matteo Levisetti, Michael L. Gross, Osami Kanagawa, Shirley J. Petzold, James J. Walters, Mark J. Miller and Katherine E. Frederick and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Anish Suri

34 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anish Suri United States 25 1.1k 767 439 284 280 36 1.8k
L. Rovedatti Italy 18 698 0.6× 767 1.0× 387 0.9× 347 1.2× 34 0.1× 37 1.6k
Dale R. Wegmann United States 25 1.6k 1.5× 2.4k 3.1× 1.5k 3.5× 246 0.9× 1.2k 4.4× 41 3.2k
Manuela Cappelletti Italy 16 501 0.5× 257 0.3× 88 0.2× 528 1.9× 63 0.2× 21 1.4k
Stefanie Derer Germany 23 661 0.6× 164 0.2× 136 0.3× 664 2.3× 54 0.2× 52 1.6k
Katrien Van Beneden Belgium 26 879 0.8× 191 0.2× 88 0.2× 513 1.8× 75 0.3× 57 1.8k
David G. Alleva United States 21 1.0k 0.9× 435 0.6× 276 0.6× 431 1.5× 221 0.8× 33 1.8k
Mayumi Kawada Japan 16 466 0.4× 145 0.2× 258 0.6× 644 2.3× 23 0.1× 20 1.6k
Dmitry V. Ostanin United States 20 676 0.6× 277 0.4× 147 0.3× 353 1.2× 27 0.1× 34 1.3k
Ignacio Benedicto Spain 22 237 0.2× 116 0.2× 152 0.3× 642 2.3× 99 0.4× 37 1.6k
Madhan Masilamani United States 24 918 0.8× 76 0.1× 190 0.4× 283 1.0× 32 0.1× 51 1.9k

Countries citing papers authored by Anish Suri

Since Specialization
Citations

This map shows the geographic impact of Anish Suri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anish Suri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anish Suri more than expected).

Fields of papers citing papers by Anish Suri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anish Suri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anish Suri. The network helps show where Anish Suri may publish in the future.

Co-authorship network of co-authors of Anish Suri

This figure shows the co-authorship network connecting the top 25 collaborators of Anish Suri. A scholar is included among the top collaborators of Anish Suri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anish Suri. Anish Suri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zaretsky, Jesse M., Jessica Ley, Peter Oppelt, et al.. (2023). Phase 2 trial of three schedules of CUE-101 administered before surgery or chemoradiotherapy in HLA-A*0201 positive patients with HPV16+ OPSCC.. Journal of Clinical Oncology. 41(16_suppl). TPS6109–TPS6109. 1 indexed citations
2.
Chen, Lina, et al.. (2023). Understanding the spatial and functional link between the IL-2R and TCR at the immunological synapse. Biophysical Journal. 122(3). 510a–510a. 1 indexed citations
3.
Ting, Yi Tian, Jan Petersen, Sri H. Ramarathinam, et al.. (2018). The interplay between citrullination and HLA-DRB1 polymorphism in shaping peptide binding hierarchies in rheumatoid arthritis. Journal of Biological Chemistry. 293(9). 3236–3251. 73 indexed citations
4.
Yamniuk, Aaron P., Anish Suri, Stanley R. Krystek, et al.. (2016). Functional Antagonism of Human CD40 Achieved by Targeting a Unique Species-Specific Epitope. Journal of Molecular Biology. 428(14). 2860–2879. 12 indexed citations
5.
Markiewicz, Mary A., Zachary S. Buchwald, Ted H. Hansen, et al.. (2009). IL-12 Enhances CTL Synapse Formation and Induces Self-Reactivity. The Journal of Immunology. 182(3). 1351–1361. 25 indexed citations
6.
Ise, Wataru, Masako Kohyama, Katherine Nutsch, et al.. (2009). CTLA-4 suppresses the pathogenicity of self antigen–specific T cells by cell-intrinsic and cell-extrinsic mechanisms. Nature Immunology. 11(2). 129–135. 132 indexed citations
7.
Suri, Anish, James J. Walters, Henry W. Rohrs, Michael L. Gross, & Emil R. Unanue. (2008). First Signature of Islet β-Cell-Derived Naturally Processed Peptides Selected by Diabetogenic Class II MHC Molecules. The Journal of Immunology. 180(6). 3849–3856. 44 indexed citations
8.
Calderón, Boris, et al.. (2008). IFN-γ-Dependent Regulatory Circuits in Immune Inflammation Highlighted in Diabetes. The Journal of Immunology. 181(10). 6964–6974. 37 indexed citations
9.
Chang, Kuan Y., Anish Suri, & Emil R. Unanue. (2007). Predicting peptides bound to I‐Ag7 class II histocompatibility molecules using a novel expectation‐maximization alignment algorithm. PROTEOMICS. 7(3). 367–377. 15 indexed citations
10.
Felix, Nathan, David L. Donermeyer, Stephen Horváth, et al.. (2007). Alloreactive T cells respond specifically to multiple distinct peptide-MHC complexes. Nature Immunology. 8(4). 388–397. 107 indexed citations
11.
Suri, Anish, Matteo Levisetti, & Emil R. Unanue. (2007). Do the peptide-binding properties of diabetogenic class II molecules explain autoreactivity?. Current Opinion in Immunology. 20(1). 105–110. 37 indexed citations
12.
Felix, Nathan, Anish Suri, James J. Walters, et al.. (2006). I-Ep-Bound Self-Peptides: Identification, Characterization, and Role in Alloreactivity. The Journal of Immunology. 176(2). 1062–1071. 11 indexed citations
13.
Calderón, Boris, Anish Suri, & Emil R. Unanue. (2006). In CD4+ T-Cell-Induced Diabetes, Macrophages Are the Final Effector Cells that Mediate Islet β-Cell Killing. American Journal Of Pathology. 169(6). 2137–2147. 96 indexed citations
14.
Suri, Anish, James J. Walters, Matteo Levisetti, Michael L. Gross, & Emil R. Unanue. (2006). Identification of naturally processed peptides bound to the class I MHC molecule H‐2Kd of normal and TAP‐deficient cells. European Journal of Immunology. 36(3). 544–557. 21 indexed citations
15.
Suri, Anish. (2005). Natural peptides selected by diabetogenic DQ8 and murine I-Ag7 molecules show common sequence specificity. Journal of Clinical Investigation. 115(8). 2268–2276. 115 indexed citations
16.
Suri, Anish & Emil R. Unanue. (2005). The Murine Diabetogenic Class II Histocompatibility Molecule I‐Ag7: Structural and Functional Properties and Specificity of Peptide Selection. Advances in immunology. 88. 235–265. 11 indexed citations
17.
Suri, Anish, James J. Walters, Osami Kanagawa, Michael L. Gross, & Emil R. Unanue. (2003). Specificity of peptide selection by antigen-presenting cells homozygous or heterozygous for expression of class II MHC molecules: The lack of competition. Proceedings of the National Academy of Sciences. 100(9). 5330–5335. 31 indexed citations
18.
Suri, Anish, et al.. (2002). In APCs, the Autologous Peptides Selected by the Diabetogenic I-Ag7 Molecule Are Unique and Determined by the Amino Acid Changes in the P9 Pocket. The Journal of Immunology. 168(3). 1235–1243. 67 indexed citations
19.
Latek, Robert, Anish Suri, Shirley J. Petzold, et al.. (2000). Structural Basis of Peptide Binding and Presentation by the Type I Diabetes-Associated MHC Class II Molecule of NOD Mice. Immunity. 12(6). 699–710. 166 indexed citations
20.
Suri, Anish & Jonathan D. Katz. (1999). Dissecting the role of CD4+ T cells in autoimmune diabetes through the use of TCR transgenic mice. Immunological Reviews. 169(1). 55–65. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L. Rovedatti Breakdown of academic impact, for papers by Dale R. Wegmann Breakdown of academic impact, for papers by Manuela Cappelletti Breakdown of academic impact, for papers by Stefanie Derer Breakdown of academic impact, for papers by Katrien Van Beneden Breakdown of academic impact, for papers by David G. Alleva Breakdown of academic impact, for papers by Mayumi Kawada Breakdown of academic impact, for papers by Dmitry V. Ostanin Breakdown of academic impact, for papers by Ignacio Benedicto Breakdown of academic impact, for papers by Madhan Masilamani
Rankless by CCL
2026